Physician

Mandira Ray, MD

According to 2025 Medicare claims, Mandira Ray, MD (NPI: 1659338606) practices hematology/oncology in the Boston, MA market, with the plurality of this provider's patient population coming from Norfolk, MA. This provider's primary affiliated billing organization is ATRIUS HEALTH, INC. (NPI: 1871639914; TIN: 043397450) and primary practice location at 02215-3904. Ray is affiliated with the Atrius Health, Inc. (ACO ID: A5088), participating under the MSSP model.

Ray's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 352 traditional Medicare patients, billed 68,958 HCPCS/CPT codes, and received $1,380,566 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 973 prescription claims across 143 beneficiaries totaling $5,408,789 in drug costs, led by Pomalyst (Pomalidomide). 2022 DME data shows 28 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $265,707 to $1,380,566. Similarly, Part D prescription costs have moved sharply higher in recent years, from $318,694 to $5,408,789. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,284 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$690K$1.4M2015 Medicare payment: $265,707 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $569,212 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $596,351 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $865,380 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $868,965 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $981,076 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $864,976 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $965,025 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $943,720 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,380,566 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201519330,217$265,707
201623549,793$569,212
201730050,678$596,351
201832454,017$865,380
201930648,543$868,965
202036057,892$981,076
202136341,949$864,976
202235053,636$965,025
202333349,456$943,720
202435268,958$1,380,566

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.7M$5.4M2015 Drug cost: $318,694 (USD; Tot_Drug_Cst)2016 Drug cost: $406,993 (USD; Tot_Drug_Cst)2017 Drug cost: $845,078 (USD; Tot_Drug_Cst)2018 Drug cost: $861,914 (USD; Tot_Drug_Cst)2019 Drug cost: $1,489,770 (USD; Tot_Drug_Cst)2020 Drug cost: $2,900,001 (USD; Tot_Drug_Cst)2021 Drug cost: $4,593,216 (USD; Tot_Drug_Cst)2022 Drug cost: $5,083,984 (USD; Tot_Drug_Cst)2023 Drug cost: $4,889,358 (USD; Tot_Drug_Cst)2024 Drug cost: $5,408,789 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201557417$318,694
201691537$406,993
2017107652$845,078
2018130801$861,914
2019138853$1,489,770
20201681,101$2,900,001
20211341,096$4,593,216
20221351,142$5,083,984
20231391,088$4,889,358
2024143973$5,408,789

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$30K$60K2015 Medicare payment: $1,667 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $555 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $5,128 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,511 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $263 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $324 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,388 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $59,683 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R23$1,667
2016N/R12$555
2017N/R13$5,128
2018N/R12$3,511
2019N/R14$263
2020N/R17$324
2021N/R12$1,388
2022N/R28$59,683
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more238491$101
82728Ferritin (blood protein) level156360$13
80053Blood test, comprehensive group of blood chemicals157725$10
36415Insertion of needle into vein for collection of blood sample2831,053$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count259851$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide551,534$1,202,591
ImbruvicaIbrutinib611,758$980,687
LenalidomideLenalidomide671,785$792,443
JakafiRuxolitinib Phosphate361,080$611,064
NinlaroIxazomib Citrate20560$276,472

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Mandira Ray, MD?

Tedicare shows public-source Medicare data for Mandira Ray, MD (NPI 1659338606), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mandira Ray, MD have ACO affiliation data?

Mandira Ray, MD is shown with ACO affiliation data for Atrius Health, Inc. (MSSP, ACO ID A5088).

What billing organization is linked to Mandira Ray, MD?

Mandira Ray, MD is linked to ATRIUS HEALTH, INC. (billing NPI 1871639914) in the available physician profile data.

Does Mandira Ray, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.